Categories
Sandoz Inc. (“Sandoz”) is initiating a voluntary recall of 13 lots (listed below) of oral Orphenadrine Citrate 100 mg Extended Release (ER) Tablets to the consumer level.
Categories
Philips Respironics Recalls Certain V60 and V60 Plus Ventilators for Expired Adhesive that May Cause Ventilator to Stop Working With or Without an Alarm
Certain Philips Respironics V60 and V60 Plus ventilators recalled due to expired adhesive that may cause ventilator to stop delivering ventilation with or without an alarm.
Categories
Prefilled Saline Flush Syringe Conservation Strategies – Letter to Health Care Personnel
The FDA recommends conservation strategies to minimize the use of these prefilled saline flush syringes and maintain the quality and safety of care for patients.
Categories
Use and Store At-Home COVID-19 Tests Properly to Avoid Potential Harm: FDA Safety Communication
These tests can be dangerous if the parts of the test kit are swallowed or if the liquid solutions touch a person’s skin or eyes.
Categories
Celltrion USA Recalls Certain Celltrion DiaTrust COVID-19 Ag Rapid Tests for False Positive Test Results and Unauthorized Shelf Life
Certain lots of Celltrion USA’s DiaTrust COVID-19 Ag Rapid Tests are being recalled for a high number of false positives and a longer shelf life than authorized by the FDA
Categories
Do Not Use SD Biosensor STANDARD Q COVID-19 Ag Home Tests: FDA Safety Communication
These tests have not been authorized, cleared, or approved. The FDA is concerned about the risk of false results when using these tests.
Categories
SD Biosensor Recalls STANDARD Q COVID-19 Ag Home Tests That Are Not Authorized, Cleared, or Approved by the FDA and May Give False Results
SD Biosensor’s STANDARD Q COVID-19 Ag Home Tests are being recalled because they are not authorized, cleared, or approved by the FDA and may give false results.
Categories
Stop Using LuSys Laboratories COVID-19 Tests: FDA Safety Communication
The tests are likely to have a high risk of false results and are not FDA authorized, cleared, or approved.
Categories
FDA Roundup: March 15, 2022
FDA Roundup: March 15, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-march-15-2022
Categories
FDA Approves First Generic of Symbicort to Treat Asthma and COPD
FDA Approves First Generic of Symbicort to Treat Asthma and COPD
http://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-symbicort-treat-asthma-and-copd